hero section gradient
16 handpicked stocks

European Auto Surge

Discover a carefully selected group of automotive stocks positioned to benefit from Europe's surprisingly strong vehicle demand. Professional analysts have curated these companies from across the auto value chain to give you exposure to this regional growth story.

Author avatar

Han Tan | Market Analyst

Published on July 11

Your Basket's Financial Footprint

Summarise the basket market capitalisation and produce investor key takeaways following FCA guidance.

Key Takeaways for Investors:
  • Large-cap concentration generally implies lower volatility and steadier performance than small-cap, high-growth baskets.
  • Treat as a core holding for diversified portfolios rather than a speculative, high-conviction growth position.
  • Likely to deliver gradual, long-term value rather than rapid short-term upside; manage expectations accordingly.
Total Market Cap
  • PSNY: $1.98B

  • ALV: $8.98B

  • MGA: $13.02B

  • Other

About This Group of Stocks

1

Our Expert Thinking

BMW's strong European sales signal broader regional strength in the auto sector, despite global headwinds. This theme captures companies benefiting from both traditional vehicle demand and the accelerating transition to electric vehicles across Europe, offering a timely opportunity based on actual sales data.

2

What You Need to Know

This group includes companies across the entire automotive ecosystem, from major manufacturers to parts suppliers and retailers. Many have significant European operations but vary in size, specialization, and global reach, providing diverse exposure to this regional trend.

3

Why These Stocks

These companies were strategically selected to capture different aspects of Europe's auto market strength. The list includes established European automakers, EV specialists expanding into Europe, critical component suppliers, and retailers who all stand to benefit from increased production and sales volumes.

Why You'll Want to Watch These Stocks

🚗

Rising European Tide

BMW's European sales jumped 10.1% despite global headwinds, suggesting the entire European auto sector could be undervalued. This upward trend might catch many investors by surprise.

The EV Connection

Europe's strong auto market includes growing demand for electric vehicles. This group gives you exposure to both traditional car leaders and the companies powering the EV revolution.

🧩

Beyond the Manufacturers

The smartest investors know strong car sales boost the entire ecosystem. This group includes component makers, electronics specialists, and retailers who often see bigger percentage gains than the major automakers themselves.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Global Infrastructure Partners: UAE Exposure Risks

Global Infrastructure Partners: UAE Exposure Risks

The UAE's strategic push for economic diversification and smart city development is creating significant demand for advanced construction and infrastructure solutions. This basket provides exposure to a selection of US and EU-listed companies that supply essential materials, technology, and engineering services to the region's projects.

UAE Infrastructure Global Suppliers Breakdown

UAE Infrastructure Global Suppliers Breakdown

As the UAE continues its ambitious economic diversification, demand for world-class infrastructure creates opportunities for the companies that build it. This basket offers exposure to US and EU-listed industrial, materials, and technology firms that are integral to developing these large-scale projects.

Antiviral M&A Wave: Biotech Opportunities in 2025

Antiviral M&A Wave: Biotech Opportunities in 2025

Merck's $9.2 billion acquisition of Cidara Therapeutics strengthens its antiviral pipeline as a key patent nears expiry. This major deal signals a growing trend of pharmaceutical giants buying smaller biotechs, creating potential opportunities among companies with promising infectious disease therapies.

Frequently Asked Questions